Skip to main content
Open Access Publications from the University of California

Clinically meaningful tumor reduction rates vary by prechemotherapy MRI Phenotype and tumor subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657): Mukhtar RA, Yau C, Rosen M, et al (Univ of California, San Francisco; Univ of Pennsylvania, Philadelphia) Ann Surg Oncol 20:3823-3830, 2013

Main Content
Current View